Wednesday, October 23, 2024

The Left is Using Bogus COVID-19 Research to Censor Their Opponents; US FDA Pauses Novavax's Trial of Combo COVID-Flu Shot On Safety Concerns, and other C-Virus related stories

AP
The left is using bogus COVID-19 research to censor their opponents:
How does one justify squelching free speech and censoring opponents?
By justifying it by “science.”
The authors of a new study published by the scientific journal Nature submit that “differential sharing of misinformation by people identifying with different political groups could lead to political asymmetries in enforcement, even by unbiased policies.”
In plain English: Conservatives face more punishment by social media companies because they share more misinformation.
How did they reach such a conclusion?
By grading a number of news outlets and then knocking conservative users for sharing links to sites the researchers themselves deemed were “low quality.”
The takeaway: Those aforementioned sanctions against right-wing speech are justified.
Fact-check scheme
There are some glaringly obvious issues with this construction.
According to the study, outlets favored by conservatives — like The Post and Fox News — are of a lesser quality than The New York Times and CBS News, because they are less prone to being tsk-tsked by biased fact-checkers who themselves often turn out to be wrong.
It’s a rigged game built on circular logic, not objective measures.
Liberals affirming other liberals’ reporting isn’t confirmation of that reporting’s validity, it’s proof that this study is tainted by confirmation bias.
Contrary to the authors’ assumption, neither the right nor the left has a monopoly on good or bad sources.
But let’s say you give the Times the nod over The Post, too (shame on you, by the way).
How does the study account for the Gray Lady accusing Sen. Tom Cotton of repeating a “fringe theory of coronavirus origins” when he posited that COVID-19 might have escaped from the coronavirus research facility in Wuhan?
Or for the widely panned, ahistorical 1619 Project?
Or for the Trump assassination fantasy it published in its book review section?
Or any number of other either mistakes or intentional obfuscations it has made in just the last few years? --->READ MORE HERE
REUTERS/Dado Ruvic/Illustration/File Photo 
US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns:
The U.S. Food and Drug Administration has put on hold a trial of Novavax's (NVAX.O) COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported nerve damage, the company said on Wednesday.
Its shares plunged as much as 24%, and if losses hold, it would wipe off nearly $400 million from the vaccine maker's market capitalization.
The stock drop also reflect concerns on whether the hold would impact Novavax's partnership with French drugmaker Sanofi (SASY.PA) according to one analyst.
Novavax said a participant enrolled in a mid-stage study of the combination vaccine last month reported symptoms of motor neuropathy, or damage to the nerve cells that control muscles or movement. The person was given the vaccine in January last year.
The company said it was not yet established that the vaccine had caused the safety event and it was working with the FDA to resolve the pause.
"Our goal is to successfully resolve this matter and to start our Phase 3 trial as soon as possible," Chief Medical Officer Robert Walker said.
At least two analysts said it was too early to draw a conclusion. Jefferies analyst Roger Song said motor neuropathy was not a side effect seen in any older trials of Novavax's shots.
Still, the pause fueled investor worries over the company's growth as its COVID-19 shot, Novavax's only approved product, faces low demand after a late entry into the U.S. market. --->READ MORE HERE
Follow links below to relevant/related stories and resources:

Covid XEC warning as doctors say new variant shows symptoms in specific order

New COVID strain is circulating in the US, what to know about the XEC variant

USA TODAY: Coronavirus Updates

WSJ: Coronavirus Live Updates

YAHOO NEWS: Coronavirus Live Updates

NEW YORK POST: Coronavirus The Latest

If you like what you see, please "Like" and/or Follow us on FACEBOOK here, GETTR here, and TWITTER here.


No comments: